Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Cronos Group | CRON | Nov 1, 2024 | 2.16 | +3.35 |
Cross Country Healthcare | CCRN | Nov 1, 2024 | 11.33 | -0.70 |
Cross Timbers Royalty Royalty Trust | CRT | Nov 1, 2024 | 9.86 | -2.86 |
CrossAmerica Partners LP Unit | CAPL | Nov 1, 2024 | 21.26 | -0.37 |
CrossFirst Bankshares | CFB | Nov 1, 2024 | 15.70 | 0.00 |
CrowdStrike A | CRWD | Nov 1, 2024 | 303.13 | +2.11 |
Crown Castle | CCI | Nov 1, 2024 | 106.58 | -0.85 |
Crown Crafts | CRWS | Nov 1, 2024 | 4.55 | +0.22 |
Crown ElectroKinetics | CRKN | Nov 1, 2024 | 0.96 | +0.02 |
Crown Holdings | CCK | Nov 1, 2024 | 93.76 | +0.22 |
Crown LNG | CGBS | Nov 1, 2024 | 0.27 | -1.12 |
Cryo-Cell International | CCEL | Nov 1, 2024 | 7.21 | -1.77 |
CryoPort | CYRX | Nov 1, 2024 | 7.15 | +7.36 |
CS Disco | LAW | Nov 1, 2024 | 6.00 | +2.04 |
CSG Systems International | CSGS | Nov 1, 2024 | 46.59 | -0.04 |
CSP | CSPI | Nov 1, 2024 | 12.20 | -2.17 |
CSW Industrials | CSWI | Nov 1, 2024 | 358.45 | +1.52 |
CSX | CSX | Nov 1, 2024 | 33.39 | -0.74 |
CTO Realty Growth | CTO | Nov 1, 2024 | 19.40 | +0.26 |
CTO Realty Growth A Pref | CTO-A | Nov 1, 2024 | 24.30 | -0.67 |
CTS | CTS | Nov 1, 2024 | 51.17 | +3.39 |
CubeSmart | CUBE | Nov 1, 2024 | 47.33 | -1.07 |
Cue Biopharma | CUE | Nov 1, 2024 | 1.52 | -5.59 |
Cullen Frost Bankers B Pref | CFR-B | Nov 1, 2024 | 19.82 | -2.41 |
Cullen/Frost Bankers | CFR | Nov 1, 2024 | 125.98 | -1.08 |
Cullinan Therapeutics | CGEM | Nov 1, 2024 | 15.78 | +1.48 |
Cullman Bancorp | CULL | Nov 1, 2024 | 9.71 | 0.00 |
Culp | CULP | Nov 1, 2024 | 5.28 | -0.57 |
Cumberland Pharmaceuticals | CPIX | Nov 1, 2024 | 1.12 | 0.00 |
Cummins | CMI | Nov 1, 2024 | 328.51 | -0.14 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.